These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9605144)

  • 1. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice.
    Doherty TM; Sher A
    J Immunol; 1998 Jun; 160(11):5428-35. PubMed ID: 9605144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
    Silva RA; Pais TF; Appelberg R
    J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
    Doherty TM; Sher A
    J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
    Kim SH; Cho D; Kim TS
    Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.
    Wagner D; Sangari FJ; Kim S; Petrofsky M; Bermudez LE
    J Leukoc Biol; 2002 Jan; 71(1):80-8. PubMed ID: 11781383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene.
    Gomes MS; Flórido M; Pais TF; Appelberg R
    J Immunol; 1999 Jun; 162(11):6734-9. PubMed ID: 10352292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice.
    Castro AG; Silva RA; Appelberg R
    J Immunol; 1995 Aug; 155(4):2013-9. PubMed ID: 7636252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.
    Petrofsky M; Bermudez LE
    Clin Immunol; 1999 Jun; 91(3):354-8. PubMed ID: 10370382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.
    Flynn JL; Goldstein MM; Triebold KJ; Sypek J; Wolf S; Bloom BR
    J Immunol; 1995 Sep; 155(5):2515-24. PubMed ID: 7650381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.
    Kawakami K; Hossain Qureshi M; Zhang T; Koguchi Y; Xie Q; Kurimoto M; Saito A
    Cell Immunol; 1999 Oct; 197(1):55-61. PubMed ID: 10555996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to the African trypanosomes is IFN-gamma dependent.
    Hertz CJ; Filutowicz H; Mansfield JM
    J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.
    Hayashi T; Rao SP; Takabayashi K; Van Uden JH; Kornbluth RS; Baird SM; Taylor MW; Carson DA; Catanzaro A; Raz E
    Infect Immun; 2001 Oct; 69(10):6156-64. PubMed ID: 11553555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production.
    Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L
    Arthritis Rheum; 2002 Mar; 46(3):806-17. PubMed ID: 11920419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.